NEOPLASTIC HEMATOPOIETIC CELL GROWTH--INTERACTIONS WITH RETROVIRUSES

肿瘤造血细胞生长——与逆转录病毒的相互作用

基本信息

  • 批准号:
    3963338
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Binding of the regulatory peptide, interleukin 2 (IL 2) to its specific receptor is a prerequisite for activated T-lymphocytes to grow. Recombinant purified IL 2 has been used to identify post-receptor events important in mediating IL 2 function. (Ca++) mobilization, protein kinase C activation and phosphoinositol hydrolysis has all been found to correlate with IL 2 induced gene activation. The genes activated by IL 2 have included those for the IL 2 receptor, gamma interferon and the proto-oncogenes, c-fos, c-myb and c-myc. IL 2 stimulation of IL 2 receptor gene transcription results in an increase of receptors on the cell surface of low affinity for IL 2. Further studies of IL 2 receptor distribution has shown it also to be expressed on immature thymocytes, monocytes/macrophages, mast cells and a variety of hematopoietic progenitor cells. In these cells, the IL 2 receptor gene is under the transscriptional control of hematopoietic growth factors such as interleukin-3 and granulocyte/macrophage colony stimulating factor. Studies were conducted concerning the mechanism of myeloid cell differentiation. Variants of the murine myelomonocytic leukemia cell line such as WEHI-3B D+ which can be induced to differentiate into monocyte/macrophages and the WEHI-3B D- is unresponsive to these inducers were developed. The unresponsive cell line was induced to differentiate to granulocytes as well as monocytes by 1,25 dihydroxy-cholcalciferol (1,25 (OH)2 D3), the biologically active metabolite of Vitamin D3. The differentiation of both cell types was accompanied by cessation of cellular growth accompanies changes in morphologic and cytochemical properties of the cells. This suggests that leukemic cells unresponsive to differentiation agents acting at the cell surface retain their ability to differentiate in response to agents that do not act via the plasma membrane such as 1,25 (OH)2 D3 which has cytosolic/nuclear receptors. Regulation of proto-oncogene transcription was also studied in these cell lines. Expression of c-fos, c-myc and c-myb was identical in the subclones whether the cells differentiated or not suggesting that expression of these genes was not sufficient to induce differentiation.
调节肽--白介素2与其特异性结合 受体是激活的T淋巴细胞生长的先决条件。 重组纯化的IL-2已用于鉴定受体后事件 在调节IL-2功能中起重要作用。(Ca++)动员,蛋白激酶 C的激活和磷酸肌醇的水解都被发现是相关的。 IL-2诱导的基因激活。IL-2激活的基因有 包括IL-2受体、γ-干扰素和 原癌基因c-fos、c-myb和c-myc。IL-2对IL-2受体的刺激作用 基因转录导致细胞表面受体增加 对IL-2的低亲和力。IL-2受体分布的进一步研究 研究表明,它也表达在未成熟的胸腺细胞上, 单核/巨噬细胞、肥大细胞和多种造血祖细胞 细胞。在这些细胞中,IL-2受体基因处于 造血生长因子的转录调控 白细胞介素3和粒细胞/巨噬细胞集落刺激因子。 对髓系细胞的机制进行了研究。 差异化。小鼠粒单核细胞白血病细胞系的变异 如WEHI-3B D+,可诱导分化为 单核/巨噬细胞和WEHI-3B D-对这些诱导剂无反应 都被开发出来了。无反应的细胞系被诱导分化为 1,25-二羟基胆钙化醇(1,25)对粒细胞和单核细胞的作用 (OH)2D3),维生素D3的生物活性代谢物。这个 两种细胞类型的分化都伴随着细胞的停止。 生长伴随着细胞形态和细胞化学性质的变化 这些细胞。这表明白血病细胞对 作用于细胞表面的分化剂保持了它们的能力 对不通过质膜起作用的药物作出反应而区别对待 如具有胞液/核受体的1,25(OH)2D3。规管 原癌基因转录也在这些细胞系中进行了研究。 C-fos、c-myc和c-myb在亚克隆中的表达是否相同 细胞分化与否表明这些基因的表达 不足以诱导分化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

F W RUSCETTI其他文献

F W RUSCETTI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('F W RUSCETTI', 18)}}的其他基金

INTERACTIONS OF HUMAN RETROVIRUSES WITH HEMATOPOIETIC AND ADHERENT CELLS
人类逆转录病毒与造血细胞和贴壁细胞的相互作用
  • 批准号:
    3896343
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
INTERACTIONS OF HUMAN RETROVIRUSES WITH HEMATOPOIETIC AND ADHERENT CELLS
人类逆转录病毒与造血细胞和贴壁细胞的相互作用
  • 批准号:
    3838183
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF NORMAL AND NEOPLASTIC HEMATOPOIETIC CELL GROWTH--ROLE OF BRMS
正常和肿瘤造血细胞生长的调节——BRMS 的作用
  • 批准号:
    3853293
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF NORMAL AND NEOPLASTIC HEMATOPOIETIC CELL GROWTH--ROLE OF BRMS
正常和肿瘤造血细胞生长的调节——BRMS 的作用
  • 批准号:
    3874512
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF NORMAL AND NEOPLASTIC HEMATOPOIETIC CELL GROWTH--ROLE OF BRMS
正常和肿瘤造血细胞生长的调节——BRMS 的作用
  • 批准号:
    3752469
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF NORMAL AND NEOPLASTIC HEMATOPOIETIC CELL GROWTH--ROLE OF BRMS
正常和肿瘤造血细胞生长的调节——BRMS 的作用
  • 批准号:
    3838187
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF NORMAL AND NEOPLASTIC HEMATOPOIETIC CELL GROWTH--ROLE OF BRMS
正常和肿瘤造血细胞生长的调节——BRMS 的作用
  • 批准号:
    3916663
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF NEOPLASTIC T-LYMPHOCYTE AND HEMATOPOIETIC CELL PROLIFERATION
肿瘤 T 淋巴细胞和造血细胞增殖的调节
  • 批准号:
    4692223
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
INTERACTIONS OF HUMAN RETROVIRUSES WITH HEMATOPOIETIC AND ADHERENT CELLS
人类逆转录病毒与造血细胞和贴壁细胞的相互作用
  • 批准号:
    3752465
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
INTERACTIONS OF HUMAN RETROVIRUSES WITH HEMATOPOIETIC AND ADHERENT CELLS
人类逆转录病毒与造血细胞和贴壁细胞的相互作用
  • 批准号:
    3874507
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了